Brain Pacemaker Market Report 2025

This Brain Pacemaker market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The brain pacemaker market size has grown rapidly in recent years. It will grow from $1.57 billion in 2024 to $1.82 billion in 2025 at a compound annual growth rate (CAGR) of 15.5%. The growth in the historic period can be attributed to increasing prevalence of Parkinson’s disease, continuous improvements in neuromodulation technologies, clinical success and approvals, rising awareness of movement disorders, rising healthcare expenditure.

The brain pacemaker market size is expected to see rapid growth in the next few years. It will grow to $3.19 billion in 2029 at a compound annual growth rate (CAGR) of 15.1%. The growth in the forecast period can be attributed to aging population, increased awareness and better diagnostic techniques for neurological conditions, expanding indications, improved surgical techniques, obtaining regulatory approvals for new devices, patient preference for non-pharmacological treatments. Major trends in the forecast period include advanced targeting algorithms, development of closed-loop DBS systems, integration of wireless charging capabilities, advancements in minimally invasive surgical techniques, innovations in battery technology.

The brain pacemaker market is poised for growth due to increasing neurological illnesses. These disorders affect the nervous system and stem from various factors such as aging, lifestyle choices, environmental influences, genetics, infections, injuries, healthcare disparities, urbanization, and industrialization. Brain pacemakers mitigate neurological symptoms by delivering targeted electrical impulses, thereby enhancing patients' quality of life. As reported in October 2023 by the World Federation of Neurology, over 40% of the global population suffers from neurological conditions, a figure projected to nearly double by 2050. The incidence of stroke deaths globally, currently at 9.7 million annually, is expected to rise by 50% by 2050, further fueling market growth.

Key players in the brain pacemaker sector are advancing technologies such as BrainSense to refine deep brain stimulation therapies. For instance, Medtronic launched the Percept RC deep brain stimulation system in January 2024. This innovative device, featuring BrainSense technology, captures and analyzes brain signals in real time. It enables personalized therapy adjustments, akin to cardiac pacemakers, to optimize treatment outcomes.

In September 2023, Amber Therapeutics, a UK-based company specializing in adaptive neuromodulation therapy, acquired Bioinduction Limited and its Picostim DyNeuMo neuromodulation therapy platform for an undisclosed sum. This acquisition marks a pivotal step for Amber, evolving it into an integrated developer and manufacturer of sophisticated closed-loop neuromodulation therapies. Bioinduction, also based in the UK, manufactures implantable neuromodulation devices, including self-contained cranialized brain pacemakers.

Major companies operating in the brain pacemaker market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, LivaNova PLC, Renishaw plc, Beijing PINS Medical Co. Ltd., NeuroPace Inc., SPR Therapeutics, SceneRay Co. Ltd., Nexeon MedSystems Inc., Soterix Medical Inc., BrainsGate Ltd., Functional Neuromodulation Inc., Aleva Neurotherapeutics SA, NeuroSigma Inc., NeuroOne Medical Technology, Fisher Wallace Laboratories Inc., Bioinduction Limited, Neuronetics Inc., Synchron Inc., Neuro Device Group S.A.

North America was the largest region in the brain pacemaker market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the brain pacemaker market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the brain pacemaker market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

A brain pacemaker, an implantable medical device, treats neurological conditions such as Parkinson's disease and epilepsy. It involves electrodes implanted in specific brain regions linked to a pulse generator in the chest. This device sends electrical impulses to regulate abnormal brain activity.

Brain pacemakers come in two main types single channel and dual channel. A single channel brain pacemaker delivers electrical stimulation to one brain area, addressing conditions such as dystonia, epilepsy, essential tremor, obsessive-compulsive disorder, Parkinson's disease, among others. These devices are distributed through both channel and direct sales, targeting end users such as hospitals, ambulatory surgical centers, and clinics.

The brain pacemaker market research report is one of a series of new reports that provides brain pacemaker market statistics, including the brain pacemaker industry global market size, regional shares, competitors with brain pacemaker market share, detailed brain pacemaker market segments, market trends, and opportunities, and any further data you may need to thrive in the brain pacemaker industry. These brain pacemaker market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The brain pacemaker market consists of sales of patient controller, programming device, extension wires, and pulse generator. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.